DIM
BEAM icon

DC Investments Management’s Beam Therapeutics BEAM Stock Holding History

DC Investments Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-21,010
Closed -$1.67M – 48
2021
Q4 		$1.67M Hold
21,010
– – 2.38% 10
2021
Q3 		$1.83M Hold
21,010
– – 3.41% 7
2021
Q2 		$2.7M Hold
21,010
– – 6.36% 2
2021
Q1 		$1.68M Sell
21,010
-67,090
-76% -$6.38M 4.17% 5
2020
Q4 		$7.19M Hold
88,100
– – 17.92% 1
2020
Q3 		$2.17M Hold
88,100
– – 2.37% 9
2020
Q2 		$2.47M Hold
88,100
– – 0.91% 13
2020
Q1 		$1.59M Buy
+88,100
New +$1.91M 1.29% 10

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DC Investments Management's BEAM Position: Q1 2022 in Review

DC Investments Management sold out of Beam Therapeutics (BEAM) in Q1 2022, closing a stake of 21,010 shares — an estimated $1.67M sold.

DC Investments Management first reported a position in BEAM in Q1 2020 and held it in 8 quarters. The position peaked at $7.19M in Q4 2020. 240 funds tracked by Wall St. Rank hold BEAM as of Q1 2022.

  • DC Investments Management reported no remaining Beam Therapeutics position as of Q1 2022 after selling out during the quarter.
  • DC Investments Management sold 21,010 Beam Therapeutics shares in Q1 2022, an estimated $1.67M.
  • DC Investments Management first reported a position in Beam Therapeutics in Q1 2020 and held it in 8 quarters.
  • DC Investments Management's Beam Therapeutics position peaked at $7.19M in Q4 2020.
  • 240 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2022.

Based on DC Investments Management's 13F filing for Q1 2022, filed 13 May 2022.